1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Transforming Cancer Treatment with Immunotherapy (TechVision) 

Transforming Cancer Treatment with Immunotherapy (TechVision) 

  • September 2015
  • 51 pages
  • ID: 3312523

Summary

Table of Contents

Transforming cancer treatment with Immunotherapy (TechVision) : Fight cancer with Immunotherapy

Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry- The progress in this space has been rather substantial on both the technical and commercial front- There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies- Cancer immunotherapy is essentially garnering one’s own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within- This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there- The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry-

Scope

Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry- The progress in this space has been rather substantial on both the technical and commercial front- There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies- Cancer immunotherapy is essentially garnering one’s own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within-

This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there- The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry-

This research service brings out the emerging trends cancer immunotherapy on a global scale, through a detailed strategic assessment of the industry environment, including:

• Technology overview
• Clinical trial data and technology segmentation, as well ad pertinent drivers and restraints that are impacting the growth of the industry-
• Industrial trends across the entire cancer immunotherapy space and information surrounding venture capital investments
• List of key patents of noteworthy innovations of global participants and a detailed list of key contacts in the field-

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Cancer Immunotherapy Market: Focus on Pharmaceutical Products, Therapeutic Indication, Competitive Landscape and Region - Analysis and Forecast, 2018-2028

Global Cancer Immunotherapy Market: Focus on Pharmaceutical Products, Therapeutic Indication, Competitive Landscape and Region - Analysis and Forecast, 2018-2028

  • $ 5000
  • February 2019

Global Cancer Immunotherapy Market to Reach $170.70 billion by 2028The healthcare industry is a multi-billion-dollar market consisting of various verticals aimed at improving patient lives.The industry ...

Chordoma Global Clinical Trials Review, H2, 2018

Chordoma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • December 2018

Chordoma Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Chordoma Global Clinical Trials Review, H2, 2018" provides an overview of Chordoma clinical trials scenario.This ...

Cancer Vaccines: Analytical Tool

Cancer Vaccines: Analytical Tool

  • $ 3950
  • December 2018

With the first prophylactic cancer vaccine Gardasil approved in 2006 and therapeutic cancer vaccine Sipuleucel-T (Provenge) approved in 2010, cancer vaccines is a proven hot treatment modality which is ...


ref:plp2015

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on